NCT01751308 2016-08-12
Safety and Efficacy of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors
Sanofi
Phase 1/2 Completed
Clinical Trials
1 trialsMalignant Solid Tumor - Malignant Nervous System Neoplasm × cabazitaxel × Other solid neoplasm × Clear all